Psychemedics Corporation (PMD)

NASDAQ: PMD · IEX Real-Time Price · USD
2.930
-0.120 (-3.93%)
At close: Mar 28, 2024, 4:00 PM
3.030
+0.100 (3.41%)
After-hours: Mar 28, 2024, 6:30 PM EDT
-3.93%
Market Cap 17.41M
Revenue (ttm) 22.10M
Net Income (ttm) -4.15M
Shares Out 5.80M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE n/a
Dividend $0.14 (4.78%)
Ex-Dividend Date May 24, 2023
Volume 14,248
Open 3.000
Previous Close 3.050
Day's Range 2.880 - 3.000
52-Week Range 2.060 - 5.630
Beta 0.67
Analysts n/a
Price Target n/a
Earnings Date Mar 28, 2024

About PMD

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ati... [Read more]

Sector Healthcare
Founded 1986
Employees 133
Stock Exchange NASDAQ
Ticker Symbol PMD
Full Company Profile

Financial Performance

In 2023, Psychemedics's revenue was $22.10 million, a decrease of -12.45% compared to the previous year's $25.24 million. Losses were -$4.15 million, 283.2% more than in 2022.

Financial Statements

News

Psychemedics Corporation Reports 2023 Financial Results

DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's leading provider of hair testing for drugs of abuse, announced today financial results for the year ended...

20 hours ago - GlobeNewsWire

Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider

Dallas, TX, March 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Em...

7 days ago - GlobeNewsWire

Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas

ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, proudly announces the relocation of its corporate headquarters from Acton,...

3 months ago - GlobeNewsWire

Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance

ACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as it...

4 months ago - GlobeNewsWire

Psychemedics Corporation Reports Third Quarter 2023 Financial Results

ACTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a leading provider of hair testing for drugs of abuse, today announced financial results for the third quarter e...

5 months ago - GlobeNewsWire

Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen

Psychemedics debuts a 5-panel drug test replacing marijuana with fentanyl, the first hair drug test exclusively targeting the most dire workplace threats.

5 months ago - GlobeNewsWire

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world's largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker ...

6 months ago - GlobeNewsWire

Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ACTON, Mass., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, announced the grant of inducement awards to its...

7 months ago - GlobeNewsWire

Psychemedics Corporation Reports Second Quarter 2023 Financial Results

ACTON, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the secon...

8 months ago - GlobeNewsWire

Psychemedics Corporation Announces CEO Succession Plan

Brian Hullinger Will Succeed Ray Kubacki as CEO Effective August 17, 2023 Mr. Hullinger Brings 30 Years of Leadership Experience and a Proven Track Record of Driving Growth ACTON, Mass.

9 months ago - GlobeNewsWire

Psychemedics Corporation Reports First Quarter 2023 Financial Results and Declares Cash Dividend

ACTON, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first ...

11 months ago - GlobeNewsWire

Psychemedics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year f...

1 year ago - GlobeNewsWire

Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third...

1 year ago - GlobeNewsWire

Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the secon...

1 year ago - GlobeNewsWire

Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.'s Retirement after More than 20 Years of Dedicated Service

ACTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced today that it will be nominating Peter H. Kamin and Darius G. Nevin to serve as new members of its Boar...

1 year ago - GlobeNewsWire

Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend

ACTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first ...

2 years ago - GlobeNewsWire

Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results

ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year f...

2 years ago - GlobeNewsWire

Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Connick From His Director Role

ACTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, is pleased to welcome Andrew “Drew” M. Reynolds...

2 years ago - GlobeNewsWire

Psychemedics Corporation Declares Cash Dividend

ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced that it has declared a cash divi...

2 years ago - GlobeNewsWire

Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021

ACTON, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third ...

2 years ago - GlobeNewsWire

Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results

ACTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the second...

2 years ago - GlobeNewsWire

5 Undervalued Stocks Trading Below the Peter Lynch Value

According to the GuruFocus All-in-One Screener, a Premium feature, as of June 28, the following companies are trading below their Peter Lynch fair values with wide margins of safety and have had posit...

Other symbols: BDNGPINNITPH
2 years ago - GuruFocus

Montana Advisors Writes Open Letter to Psychemedics

MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time...

3 years ago - Business Wire

Psychemedics Corporation Reports First Quarter 2021 Financial Results

ACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first q...

3 years ago - GlobeNewsWire

Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results

ACTON, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced fourth quarter and full year fi...

3 years ago - GlobeNewsWire